Keyphrases
Long-term Safety
100%
Prospective Evaluation
100%
Hemodialysis Patients
100%
Sodium Ferric Gluconate Complex
100%
Adverse Events
30%
Life-threatening
15%
Angiotensin-converting Enzyme Inhibitor (ACEi)
15%
Placebo-controlled
7%
Repeated Exposure
7%
Double-blind Trial
7%
Vasodilatation
7%
Long-term Evaluation
7%
Pruritus
7%
Hypotension
7%
Re-administration
7%
Inhibitor Therapy
7%
Intolerance
7%
Maintenance Hemodialysis Patients
7%
Infusion Rate
7%
Evaluation Period
7%
Serious Events
7%
Repeated Dose
7%
Outpatient Hemodialysis
7%
Ampule
7%
Taste Loss
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Ferric Gluconate
100%
Adverse Event
30%
Dipeptidyl Carboxypeptidase Inhibitor
15%
Placebo
7%
Pruritus
7%
Hypotension
7%